Are you suffering from filler fatigue syndrome, or walking around with years of heavy, fibrotic scar tissue from old injections and energy-based treatments? In this episode of Beauty Bytes, I am thrilled to sit down with Ario Khoshbin, the founder and CEO of Phusion Labs and the former CEO of Prellenium, to discuss a massive paradigm shift in aesthetic medicine. Ario introduces a revolutionary new class of treatments: enzymatic bioremodelers. For decades, the aesthetic industry has treated the symptoms of aging by simply adding more filler to stretch the skin, which can eventually make the face look thicker and unnatural. Ario explains how we can move toward true regenerative medicine by using combination enzymes—like collagenase, lipase, and lyase—to clear out denatured collagen, shrink fat cells, and dissolve old product. We discuss why you need to "gut the house" before you renovate it, how these enzymes work together to reverse surgical fibrosis, and his new AI-driven platform that puts treatment analysis directly into the patient's hands. If you are ready to stop putting a band-aid on aging and actually restore your skin quality, this is a must-listen episode. Guest Information:Ario Khoshbin is the CEO and founder of Phusion Labs. You can explore his new AI platform by visiting phusionlabs.app or find him on social media

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related